Home›ENDOCRINOLOGY

Gestational Diabetes Diagnosis and Evaluation

Medical testing process used to detect pregnancy related diabetes

Endocrinology focuses on hormonal system and metabolic health. Learn about the diagnosis and treatment of diabetes, thyroid disorders, and adrenal conditions.

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors
GDPR

Diagnosis and Evaluation of Gestational Diabetes

Effective diagnosis and evaluation are the cornerstones of managing gestational diabetes, a condition that affects up to 10% of pregnancies worldwide. At Liv Hospital, our multidisciplinary team uses evidence‑based protocols to identify elevated blood‑sugar levels early, allowing timely intervention that protects both mother and baby. This page explains the step‑by‑step process used by our endocrinology specialists, from initial screening to postpartum follow‑up, and highlights the comprehensive support services we provide for international patients.

International patients often arrive with limited local medical records, making a thorough assessment essential. Our clinicians combine laboratory data, risk‑factor analysis, and fetal monitoring to create a personalized care plan. Whether you are seeking a routine check‑up or require urgent evaluation, the following sections outline every component of the diagnostic pathway, ensuring clarity and confidence throughout your journey.

Understanding Gestational Diabetes and Its Significance

Gestational diabetes mellitus (GDM) is glucose intolerance first recognized during pregnancy. While most cases resolve after delivery, the condition increases the risk of preeclampsia, macrosomia, and future type 2 diabetes for the mother, as well as neonatal hypoglycemia and respiratory distress for the infant.

Key points for patients:

  • Occurs typically between 24 and 28 weeks of gestation.
  • Risk factors include obesity, advanced maternal age, a family history of diabetes, and previous GDM.
  • Early detection through systematic diagnosis and evaluation reduces complications.

Our clinicians employ a risk‑based approach, prioritizing women with multiple risk factors for early screening, while offering universal testing to all pregnant patients at the recommended gestational window.

Risk Stratification Checklist

Risk Factor

Impact on Screening Timing

Body mass index (BMI) ≥ 30 kg/m²

Screen at 16–20 weeks

Previous GDM or macrosomic infant

Screen at 16–20 weeks

Family history of type 2 diabetes

Screen at 24–28 weeks (standard)

Polycystic ovary syndrome (PCOS)

Screen at 24–28 weeks (standard)

By integrating these criteria into the initial consultation, Liv Hospital ensures that every patient receives the appropriate timing for testing, paving the way for accurate diagnosis and evaluation.

shutterstock 2491768359 LIV Hospital

Screening Tests: Oral Glucose Challenge and Tolerance Tests

The first step in the diagnostic pathway is a screening test that is simple, low‑cost, and highly sensitive. Two primary methods are used:

  • One‑Hour 50‑g Oral Glucose Challenge Test (OGCT) – The patient drinks a glucose solution and blood is drawn after one hour. A result ≥140 mg/dL typically warrants a diagnostic test.
  • Two‑Hour 75‑g Oral Glucose Tolerance Test (OGTT) – Conducted if the OGCT is abnormal or if the patient has high‑risk factors. Blood glucose is measured fasting, at one hour, and at two hours after ingestion.

Interpretation thresholds for the 75‑g OGTT (based on WHO criteria) are:

  • Fasting ≥92 mg/dL
  • 1‑hour ≥180 mg/dL
  • 2‑hour ≥153 mg/dL

Only one abnormal value is needed for a positive diagnosis. At Liv Hospital, the tests are performed in a comfortable, private setting with multilingual staff to guide international patients through the procedure.

Preparation Guidelines for Patients

To ensure accurate results, patients should:

  • Fast for at least 8 hours before the OGTT (water is permitted).
  • Avoid excessive physical activity the day before testing.
  • Notify the clinic of any medications that may affect glucose metabolism.

These simple steps enhance the reliability of the diagnosis and evaluation process, allowing clinicians to make confident treatment decisions.

Laboratory Evaluation: Beyond Glucose Measurements

While glucose levels are the primary diagnostic markers, a comprehensive laboratory panel provides insight into the metabolic environment and potential complications.

  • HbA1c – Reflects average glucose over the previous 2–3 months; useful for distinguishing pre‑existing diabetes.
  • Serum insulin and C‑peptide – Help assess pancreatic beta‑cell function.
  • Lipid profile – Elevated triglycerides may accompany GDM and increase cardiovascular risk.
  • Renal function tests (creatinine, eGFR) – Important for medication dosing and monitoring.

All laboratory results are entered into Liv Hospital’s integrated electronic health record, which automatically flags abnormal values for the endocrinology team. This seamless flow of data accelerates the overall diagnosis and evaluation timeline.

Sample Laboratory Report

Test

Result

Reference Range

Fasting Glucose

95 mg/dL

70–99 mg/dL

1‑Hour OGTT

185 mg/dL

≤180 mg/dL

2‑Hour OGTT

158 mg/dL

≤153 mg/dL

HbA1c

5.8 %

4.0–5.6 %

In this example, the elevated 1‑hour and 2‑hour values confirm a diagnosis of gestational diabetes, prompting the next phase of evaluation and management.

shutterstock 2606524751 LIV Hospital

Clinical Assessment and Risk Factor Review

Laboratory data are complemented by a thorough clinical interview that captures lifestyle, medical history, and psychosocial factors. This holistic approach ensures that treatment plans are realistic and culturally appropriate for international patients.

  • Medical History – Prior pregnancies, existing chronic conditions, and medication use.
  • Family History – Diabetes, hypertension, or cardiovascular disease in first‑degree relatives.
  • Dietary Habits – Typical carbohydrate intake, cultural food preferences, and nutritional supplements.
  • Physical Activity – Frequency, intensity, and barriers to exercise.

Our clinicians also assess psychosocial stressors, language barriers, and travel logistics that may affect adherence to monitoring and therapy. By documenting these elements, the team can tailor education materials and follow‑up schedules, reinforcing the overall diagnosis and evaluation framework.

Standardized Assessment Form

All patients complete a structured questionnaire, which includes:

  • Age, height, weight, and BMI.
  • Gestational age at first prenatal visit.
  • Previous obstetric outcomes.
  • Current symptoms (e.g., polyuria, fatigue).
  • Socio‑economic considerations (insurance, travel plans).

The collected information is reviewed by the endocrinology, obstetrics, and nutrition teams during a joint case conference.

Imaging and Fetal Monitoring in the Evaluation Process

Once gestational diabetes is confirmed, fetal well‑being becomes a central focus. Ultrasound examinations and Doppler studies provide real‑time data on fetal growth and amniotic fluid volume.

  • Anatomical Ultrasound (18–22 weeks) – Establishes baseline fetal measurements.
  • Growth Ultrasound (every 4 weeks after diagnosis) – Detects macrosomia early.
  • Doppler Velocimetry – Assesses placental blood flow, especially in high‑risk cases.
  • Non‑Stress Test (NST) – Evaluates fetal heart rate patterns after 32 weeks.

Liv Hospital’s imaging department uses high‑resolution equipment operated by certified sonographers who are experienced in managing diverse patient populations. Results are instantly shared with the endocrine and obstetric teams, allowing rapid adjustments to the treatment plan.

Typical Imaging Schedule

Gestational Age

Imaging Modality

Purpose

12–14 weeks

Transvaginal Ultrasound

Confirm viability, baseline measurements

24–28 weeks

Anatomical Ultrasound

Detect anomalies, establish growth curve

28–36 weeks (every 4 weeks)

Growth Ultrasound

Monitor for macrosomia, amniotic fluid

32 weeks onward

Non‑Stress Test

Assess fetal heart rate reactivity

These imaging milestones are integrated into the overall diagnosis and evaluation pathway, ensuring that both maternal metabolic control and fetal development are closely tracked.

shutterstock 2738811345 LIV Hospital

Post‑Diagnosis Follow‑Up and Postpartum Evaluation

After a gestational diabetes diagnosis, patients enter a structured follow‑up schedule that includes glucose monitoring, dietary counseling, and periodic laboratory reassessment.

  • Self‑Monitoring of Blood Glucose (SMBG) – Typically four times daily (fasting and post‑prandial).
  • Nutrition Consultation – Individualized meal plans respecting cultural preferences.
  • Pharmacologic Therapy – Insulin or oral agents when lifestyle measures are insufficient.
  • Postpartum OGTT (6–12 weeks after delivery) – Determines whether glucose intolerance persists.

International patients benefit from Liv Hospital’s tele‑medicine platform, which enables remote SMBG data upload and virtual consultations, reducing the need for repeated travel.

Postpartum OGTT Interpretation

Result

Interpretation

Next Steps

Normal (<92 mg/dL fasting, <180 mg/dL 1‑hr, <153 mg/dL 2‑hr)

Resolved GDM

Routine annual screening

Impaired Glucose Tolerance

Elevated but not diabetic

Lifestyle modification, repeat testing in 1 year

Diabetes Mellitus

Diagnostic thresholds met

Referral to diabetes specialist

Continued surveillance after delivery aligns with the comprehensive diagnosis and evaluation philosophy, safeguarding long‑term health for both mother and child.

Multidisciplinary Care Model at Liv Hospital

Effective management of gestational diabetes relies on coordinated care among endocrinologists, obstetricians, nutritionists, neonatologists, and patient‑support services. Liv Hospital’s model emphasizes seamless communication and culturally sensitive support for international patients.

  • Endocrinology Team – Leads the diagnostic work‑up, prescribes therapy, and adjusts treatment based on SMBG trends.
  • Obstetrics Department – Monitors pregnancy progression, schedules ultrasounds, and plans delivery timing.
  • Nutrition Services – Provides meal planning in multiple languages, considering dietary restrictions.
  • Patient Liaison – Assists with travel arrangements, interpreter services, and accommodation.
  • Tele‑Health Coordination – Enables remote follow‑up for patients returning to their home country.

Each patient receives a personalized care pathway documented in a shared digital file, ensuring that every specialist works from the same set of data. This integrated approach embodies the highest standards of diagnosis and evaluation for gestational diabetes.

shutterstock 2387574219 LIV Hospital

Why Choose Liv Hospital

Liv Hospital is a JCI‑accredited, internationally recognized center that offers a 360‑degree patient experience. Our expertise in endocrinology, combined with dedicated international patient services, ensures that you receive world‑class care from diagnosis through postpartum follow‑up. From multilingual coordinators to comfortable accommodation assistance, every aspect of your journey is managed with professionalism and compassion.

Ready to take control of your pregnancy health? Contact Liv Hospital today to schedule your comprehensive gestational diabetes assessment. Our expert team is prepared to guide you through every step of the diagnosis and evaluation process, ensuring a safe and healthy outcome for you and your baby.

liv-hospital-i

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

Related Doctors

Assoc. Prof. MD. Seda Turgut Liv Hospital Ulus Assoc. Prof. MD. Seda Turgut Endocrinology and Metabolism Prof. MD. Demet Yetkin Liv Hospital Ulus Prof. MD. Demet Yetkin Endocrinology and Metabolism Prof. MD. Berçem Ayçiçek Liv Hospital Vadistanbul Prof. MD. Berçem Ayçiçek Endocrinology and Metabolism Prof. MD. Gönül Çatlı Liv Hospital Vadistanbul Prof. MD. Gönül Çatlı Pediatric Endocrinology Prof. MD. Kubilay Ükinç Liv Hospital Vadistanbul Prof. MD. Kubilay Ükinç Endocrinology and Metabolism Assoc. Prof. MD. Sevil Arı Yuca Liv Hospital Bahçeşehir Assoc. Prof. MD. Sevil Arı Yuca Pediatric Endocrinology and Metabolic Diseases Assoc. Prof. MD. Ufuk Özuğuz Liv Hospital Bahçeşehir Assoc. Prof. MD. Ufuk Özuğuz Endocrinology and Metabolism Spec. MD. Hüseyin Çelik Liv Hospital Bahçeşehir Spec. MD. Hüseyin Çelik Endocrinology and Metabolism Prof. MD. Mehmet Aşık Liv Hospital Topkapı Prof. MD. Mehmet Aşık Endocrinology and Metabolism Prof. MD. Nujen Çolak Bozkurt Liv Hospital Topkapı Prof. MD. Nujen Çolak Bozkurt Endocrinology and Metabolism Prof. MD. Banu Aktaş Yılmaz Liv Hospital Ankara Prof. MD. Banu Aktaş Yılmaz Endocrinology and Metabolism Prof. MD. Peyami Cinaz Liv Hospital Ankara Prof. MD. Peyami Cinaz Pediatric Endocrinology Prof. MD. Serdar Güler Liv Hospital Ankara Prof. MD. Serdar Güler Endocrinology and Metabolism Spec. MD. Elif Sevil Alagüney Liv Hospital Ankara Spec. MD. Elif Sevil Alagüney Endocrinology and Metabolism Prof. MD. Zeynel Beyhan Liv Hospital Gaziantep Prof. MD. Zeynel Beyhan Endocrinology and Metabolic Diseases Spec. MD. Tahsin Özenmiş Liv Hospital Gaziantep Spec. MD. Tahsin Özenmiş Endocrinology and Metabolism Assoc. Prof. MD. Gülçin Cengiz Ecemiş Liv Hospital Samsun Assoc. Prof. MD. Gülçin Cengiz Ecemiş Endocrinology and Metabolism Spec. MD. Esra Tutal Liv Hospital Samsun Spec. MD. Esra Tutal Endocrinology and Metabolic Diseases MD. FİDAN QULU Liv Bona Dea Hospital Bakü MD. FİDAN QULU Endocrinology and Metabolism Spec. MD. Zümrüt Kocabey Sütçü Spec. MD. Zümrüt Kocabey Sütçü Pediatric Endocrinology Prof. MD. Cengiz Kara Liv Hospital Ulus + Liv Hospital Vadistanbul + Liv Hospital Topkapı Prof. MD. Cengiz Kara Pediatric Endocrinology

30 Years of
Excellence

Trusted Worldwide

With patients from across the globe, we bring over three decades of medical

Group 346 LIV Hospital

Reviews from 9,651

4,9

Worth a look

Related Videos
Departments
Our Doctors
News

Was this article helpful?

Was this article helpful?

I didn't like it
I LIKE

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors
GDPR

FREQUENTLY ASKED QUESTIONS

What is gestational diabetes and why is early diagnosis important?

Gestational diabetes mellitus (GDM) appears typically between 24 and 28 weeks of gestation and is characterized by elevated blood‑sugar levels that develop during pregnancy. If left untreated, GDM increases the chance of preeclampsia, macrosomia, neonatal hypoglycemia, and future type 2 diabetes for the mother. Early diagnosis through systematic screening allows clinicians to implement dietary, lifestyle, and pharmacologic interventions that keep glucose under control, thereby protecting maternal health and promoting normal fetal growth.

At Liv Hospital, pregnant patients undergo a One‑Hour 50‑g Oral Glucose Challenge Test (OGCT) where they drink a glucose solution and have blood drawn after one hour. If the result is 140 mg/dL or higher, a diagnostic Two‑Hour 75‑g Oral Glucose Tolerance Test (OGTT) is scheduled. The OGTT measures fasting glucose and glucose at 1‑hour and 2‑hours after ingestion, providing definitive diagnostic information.

According to WHO criteria used at Liv Hospital, a fasting glucose level of 92 mg/dL or higher, a 1‑hour value of 180 mg/dL or higher, or a 2‑hour value of 153 mg/dL or higher indicates gestational diabetes. The presence of any single abnormal value meets the diagnostic threshold, allowing prompt initiation of management.

Beyond the glucose measurements, Liv Hospital orders HbA1c to differentiate pre‑existing diabetes, serum insulin and C‑peptide to assess beta‑cell function, a lipid profile to identify hypertriglyceridemia, and renal function tests (creatinine, eGFR) to guide medication dosing. These results are automatically flagged in the electronic health record, streamlining the overall diagnostic workflow.

International patients often arrive with limited local records. Liv Hospital provides translated intake forms, multilingual nurses to explain the OGCT/OGTT procedures, and a tele‑medicine platform that allows remote upload of self‑monitoring blood‑glucose data. The multidisciplinary team also considers language barriers, travel logistics, and cultural dietary preferences to create a personalized care plan.

Once GDM is confirmed, Liv Hospital schedules an anatomical ultrasound (18–22 weeks) to establish baseline fetal measurements, followed by growth ultrasounds every four weeks to detect macrosomia. Doppler velocimetry assesses placental blood flow in high‑risk cases, and a non‑stress test (NST) after 32 weeks monitors fetal heart‑rate reactivity, ensuring timely adjustments to the treatment plan.

Spine Hospital of Louisiana

RELATED VIDEOS

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 510 67 91
liv-hospital-seeklogo
+90 530 510 67 91
Facebook-f X-twitter Instagram Youtube Linkedin-in Tiktok

How helpful was it?

helpful
GDPR
helpful
GDPR
helpful
GDPR
Contact Us
Contact Us
Medical Second Opinion